Shineng Luo

719 total citations
41 papers, 622 citations indexed

About

Shineng Luo is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shineng Luo has authored 41 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shineng Luo's work include Radiopharmaceutical Chemistry and Applications (23 papers), Bone health and treatments (14 papers) and Medical Imaging and Pathology Studies (12 papers). Shineng Luo is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (23 papers), Bone health and treatments (14 papers) and Medical Imaging and Pathology Studies (12 papers). Shineng Luo collaborates with scholars based in China, Fiji and United States. Shineng Luo's co-authors include Ling Qiu, Jianguo Lin, Min Yang, Donghui Pan, Yuping Xu, Lizhen Wang, Xiaohong Chen, Qingguo Xie, Ning Guo and Hong Ding and has published in prestigious journals such as Chemical Communications, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Shineng Luo

39 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shineng Luo China 15 282 274 147 126 105 41 622
Dionysia Papagiannopoulou Greece 15 316 1.1× 214 0.8× 106 0.7× 99 0.8× 107 1.0× 39 574
Viola Groehn Switzerland 14 406 1.4× 160 0.6× 109 0.7× 129 1.0× 131 1.2× 23 684
Heather M. Hennkens United States 13 463 1.6× 198 0.7× 100 0.7× 144 1.1× 80 0.8× 31 645
Hancheng Cai United States 14 413 1.5× 161 0.6× 246 1.7× 96 0.8× 187 1.8× 33 750
Nadine Colpo Canada 18 534 1.9× 307 1.1× 166 1.1× 217 1.7× 95 0.9× 41 766
Marc Pretze Germany 15 286 1.0× 153 0.6× 201 1.4× 61 0.5× 161 1.5× 37 589
Benjamin B. Kasten United States 14 239 0.8× 160 0.6× 96 0.7× 108 0.9× 56 0.5× 25 512
Charmaine M. Jeffery Australia 9 272 1.0× 216 0.8× 143 1.0× 75 0.6× 55 0.5× 14 616
Gwang Il An South Korea 18 451 1.6× 184 0.7× 156 1.1× 116 0.9× 65 0.6× 41 765
Júlia Baguña Torres United Kingdom 14 209 0.7× 218 0.8× 141 1.0× 85 0.7× 33 0.3× 27 633

Countries citing papers authored by Shineng Luo

Since Specialization
Citations

This map shows the geographic impact of Shineng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shineng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shineng Luo more than expected).

Fields of papers citing papers by Shineng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shineng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shineng Luo. The network helps show where Shineng Luo may publish in the future.

Co-authorship network of co-authors of Shineng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shineng Luo. A scholar is included among the top collaborators of Shineng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shineng Luo. Shineng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qing, Chen Zhu, Yuping Xu, et al.. (2015). Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET. Journal of drug targeting. 23(9). 813–820. 31 indexed citations
2.
Liu, Yaling, Qingqing Miao, Pei Zou, et al.. (2015). Enzyme-Controlled Intracellular Self-Assembly of 18F Nanoparticles for Enhanced MicroPET Imaging of Tumor. Theranostics. 5(10). 1058–1067. 46 indexed citations
3.
Qiu, Ling, Gao‐Chao Lv, Yang Cao, et al.. (2015). Synthesis and biological evaluation of novel platinum complexes of imidazolyl-containing bisphosphonates as potential anticancer agents. JBIC Journal of Biological Inorganic Chemistry. 20(8). 1263–1275. 16 indexed citations
4.
Wang, Yang, Qingzhu Liu, Ling Qiu, et al.. (2015). Molecular structure, IR spectra, and chemical reactivity of cisplatin and transplatin: DFT studies, basis set effect and solvent effect. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 150. 902–908. 29 indexed citations
5.
Pan, Donghui, Rong Hua Yang, Lizhen Wang, et al.. (2014). A new 68Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Amino Acids. 46(6). 1481–1489. 26 indexed citations
6.
Xu, Yuping, Donghui Pan, Qing Xu, et al.. (2014). Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe 18F-FBEM–Cys39-exendin-4. Journal of Cancer Research and Clinical Oncology. 140(9). 1479–1488. 20 indexed citations
7.
Xu, Yuping, Donghui Pan, Chen Zhu, et al.. (2014). Pilot Study of a Novel 18F-labeled FSHR Probe for Tumor Imaging. Molecular Imaging and Biology. 16(4). 578–585. 32 indexed citations
8.
Guo, Ning, Donghui Pan, Chunjing Yu, et al.. (2013). First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination. Journal of Nuclear Medicine. 54(5). 691–698. 143 indexed citations
9.
Qiu, Ling, Jianguo Lin, Liqing Wang, et al.. (2013). A Series of Imidazolyl-Containing Bisphosphonates with Abundant Hydrogen-Bonding Interactions: Syntheses, Structures, and Bone-Binding Affinity. Australian Journal of Chemistry. 67(2). 192–205. 10 indexed citations
10.
Liu, Yaling, et al.. (2012). 3,4,6-Tri-O-acetyl-1,2-O-[1-(exo-ethoxy)ethylidene]-β-D-mannopyranose 0.11-hydrate. Acta Crystallographica Section C Crystal Structure Communications. 68(9). o338–o340. 3 indexed citations
11.
Lin, Jianguo, et al.. (2012). Development of superior bone scintigraphic agent from a series of 99mTc-labeled zoledronic acid derivatives. Applied Radiation and Isotopes. 70(5). 848–855. 17 indexed citations
12.
Wang, Yan, et al.. (2011). Animal studies of 99mTc–i-PIDP: A new bone imaging agent. Applied Radiation and Isotopes. 69(9). 1169–1175. 11 indexed citations
13.
Lin, Jianguo, et al.. (2011). Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative. Nuclear Medicine and Biology. 38(5). 619–629. 27 indexed citations
14.
Zou, Pei, et al.. (2010). Dimethyl 5-amino-2,4,6-triiodoisophthalate. Acta Crystallographica Section E Structure Reports Online. 66(2). o360–o360. 1 indexed citations
15.
Lin, Jianguo, et al.. (2010). Preparation and preclinical pharmacological study on a novel bone imaging agent 99mTc-EMIDP. Applied Radiation and Isotopes. 68(9). 1616–1622. 19 indexed citations
16.
Luo, Shineng, et al.. (2010). Syntheses of haptens and hapten-protein conjugates for insecticide propoxur and cyhalothrin. Science in China Series B Chemistry. 53(5). 1108–1113. 3 indexed citations
17.
Lin, Jian-Guo, et al.. (2010). A novel cobalt(II) complex based on nicotinamide and 2-nitrobenzoate mixed ligands: Synthesis, characterization, and biological activity. Inorganic Chemistry Communications. 13(7). 855–858. 12 indexed citations
18.
Liu, Yaling, et al.. (2009). Ethyl 3-carboxy-5-nitrobenzoate. Acta Crystallographica Section E Structure Reports Online. 65(5). o1174–o1174. 1 indexed citations
19.
Wu, Jun, et al.. (2009). 2-IsopropoxyphenylN-methylcarbamate. Acta Crystallographica Section E Structure Reports Online. 65(2). o381–o381.
20.
Luo, Shineng, et al.. (2008). 2-(1-Methylethoxy)-5-nitrophenylN-methylcarbamate. Acta Crystallographica Section E Structure Reports Online. 65(1). o47–o47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dionysia Papagiannopoulou Breakdown of academic impact, for papers by Viola Groehn Breakdown of academic impact, for papers by Heather M. Hennkens Breakdown of academic impact, for papers by Hancheng Cai Breakdown of academic impact, for papers by Nadine Colpo Breakdown of academic impact, for papers by Marc Pretze Breakdown of academic impact, for papers by Benjamin B. Kasten Breakdown of academic impact, for papers by Charmaine M. Jeffery Breakdown of academic impact, for papers by Gwang Il An Breakdown of academic impact, for papers by Júlia Baguña Torres
Rankless by CCL
2026